Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Key Caper d: A Survey of \Procedure and Tomfoolery Released\ Tabletop game - 2How to identify animal tracks, burrows and other signs of wildlife in your neighborhood
- 3Kona SUV: Exploring the Future with Hyundai's Visionary Hybrid
- 4Exemplary Fragrances: A Manual for Notorious Scents
- 5Shah Capital pushes for Novavax sale, warns of proxy fight
- UK clothing inflation climbs as Middle East turmoil threatens wider price rises
- Flourishing in a Cutthroat Work Market: Vocation Methodologies
- A Couple of Modest Guitars for 2024
- Find the Lively Food Markets of South America
- Qatar LNG Ships U-Turn After Attempt to Pass Through Hormuz
- Remarkable Spots for Hot Air Swelling All over The Planet
- Meet the astronauts about to make history on flight around the moon
- NASA's Perseverance Mars rover could break the record for miles driven on another planet
- Whale stranded in the Baltic Sea swims free again. It still faces a tough task
